首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta
【2h】

Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta

机译:干扰素α和β对人巨噬细胞活化的激动剂和拮抗剂作用。两类干扰素γ受体和干扰素α或β阻断高亲和力位点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

H2O2-releasing capacity and limited antitoxoplasma activity could be induced in human macrophages (derived from monocytes cultured greater than or equal to 5 d) but not in monocytes themselves (cells cultured less than or equal to 4 d) by a further 3-d incubation with pure natural or rIFN-alpha or -beta. More than 3 pM (10 U/ml) of these IFNs was required, with greatest effects at approximately 300 pM (10(3) U/ml). At 300 pM, H2O2-releasing capacity was enhanced 4.4 +/- 1.6-fold over medium control (mean +/- SD for natural INF-alpha, rIFN-alpha A, rIFN-alpha D, and rIFN-beta) compared to an 8.4 +/- 4.8-fold increase with rIFN-gamma (100 pM, 100 U/ml) in the same experiments. Unexpectedly, low concentrations of IFN-alpha or -beta (3 fM-300 pM) blocked induction of H2O2-releasing capacity by rIFN-gamma (10 pM), with a 50% inhibitory dose of approximately 80 fM. However, IFN-alpha or -beta (3 fM-300 pM) could not inhibit the effect of higher concentrations of rIFN-gamma (1 nM). In contrast to results with monocytes or young macrophages, Scatchard plots of binding of 125I-rIFN- gamma to mature macrophages (day 8 of culture) indicated two classes of binding sites: approximately 2,000 high-affinity sites (Kd approximately 0.43 nM) and approximately 23,000 low-affinity sites (Kd approximately 6.4 nM) per cell. Binding of 125I-rIFN-gamma to the high- but not the low-affinity sites was blocked by simultaneously added IFN- alpha or -beta, with a 50% inhibitory dose of approximately 2 U/0.25 ml (approximately 2 pM), or reversed by subsequently added IFN-alpha or - beta. Thus, differentiation of human mononuclear phagocytes in vitro is accompanied by the emergence of (a) an agonist response to submicromolar concentrations of IFN-alpha or -beta, (b) antagonism of the effect of picomolar IFN-gamma by femtomolar IFN-alpha or -beta, (c) two classes of IFN-gamma-Rs, and (d) nonstimulatory binding of IFN- alpha or -beta to the high- but not the low-affinity IFN-gamma-Rs, with higher affinity than rIFN-gamma itself. We speculate that traces of IFN- alpha or -beta derived from stromal cells, parenchymal cells, or resident macrophages may dampen the activation of mature tissue macrophages by the small amounts of IFN-gamma that diffuse from inflammatory sites into normal tissues. Such a mechanism could constrain the potentially destructive phenomenon of macrophage activation to areas where monocytes have recently immigrated and/or the concentration of IFNs is high.
机译:通过进一步的3 d温育,可在人巨噬细胞(源自培养大于或等于5 d的单核细胞)中诱导释放H 2 O 2的能力和有限的抗弓形体活性,但不能诱导单核细胞本身(培养小于或等于4 d的细胞)具有纯天然或rIFN-alpha或-beta。这些干扰素需要超过3 pM(10 U / ml),在约300 pM(10(3)U / ml)时效果最大。与培养基对照相比,在300 pM时,H2O2释放能力比培养基对照提高了4.4 +/- 1.6倍(天然INF-alpha,rIFN-alpha A,rIFN-alpha D和rIFN-beta的平均值+/- SD)。在同一实验中,rIFN-γ(100 pM,100 U / ml)增加8.4 +/- 4.8倍。出乎意料的是,低浓度的IFN-α或-β(3 fM-300 pM)阻止了rIFN-γ(10 pM)对H2O2释放能力的诱导,抑制率为50%,约为80 fM。但是,IFN-α或-beta(3 fM-300 pM)不能抑制更高浓度的rIFN-γ(1 nM)的作用。与单核细胞或年轻巨噬细胞的结果相反,125I-rIFN-γ与成熟巨噬细胞结合的Scatchard图(培养的第8天)显示了两类结合位点:约2,000个高亲和力位点(Kd约0.43 nM)和每个细胞23,000个低亲和力位点(Kd约为6.4 nM)。同时添加IFN-α或-β可以阻断125I-rIFN-γ与高亲和力位点的结合,但同时抑制50%抑制剂量约2 U / 0.25 ml(约2 pM),或通过随后添加IFN-α或-β逆转。因此,在体外人类单核吞噬细胞的分化伴随着(a)对亚微摩尔浓度的IFN-α或-β的激动剂反应,(b)对飞摩尔IFN-α的皮摩尔IFN-γ的拮抗作用或-β,(c)两类IFN-γ-R,以及(d)IFN-α或-β与高亲和力而不是低亲和力的IFN-γ-R的非刺激性结合,其亲和力高于rIFN-伽玛本身。我们推测,源自基质细胞,实质细胞或常驻巨噬细胞的IFN-α或-β痕迹可能会通过少量从炎症部位扩散到正常组织的IFN-γ抑制成熟组织巨噬细胞的活化。这种机制可以将巨噬细胞激活的潜在破坏性现象限制在单核细胞最近迁移和/或IFN浓度高的区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号